Anti-Human/Mouse/Rat Phospho-SMAD3 (Ser425) Antibody [4C5]
Anti-Human/Mouse/Rat Phospho-SMAD3 (Ser425) Antibody [4C5] with collaborator-tested evidence for IHC-P. Read more ›
["IHC-p"]Product Description
Phospho-SMAD3 (Ser425) is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human, Mouse, Rat; host: Mouse; clonality: Monoclonal; clone: 4C5; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC-p. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Synthetic Peptide of Phospho-Smad3 (Ser425); purification: Protein A purification; concentration: 1 mg/mL.
Database references: UniProt: P84022 | NCBI Gene: 4088.
Research Use Only.
Key Facts
| Target | Phospho-SMAD3 (Ser425) |
| Also known as | DKFZP586N0721, DKFZp686J10186, HSPC193, HST17436, JV15 2, JV15-2, JV152, LDS1C, LDS3, MAD, MAD (mothers against decapentaplegic Drosophila) homolog 3, MAD homolog 3, Mad homolog JV15 2, Mad protein homolog, hMAD 3, hMAD-3, hSMAD3, mothers against decapentaplegic homolog 3 |
| Concentration | 1 mg/mL |
| Species reactivity | Human, Mouse, Rat |
| Shelf life | 12 months from shipping dates |
| Research area | Cancer, Epigenetics and Nuclear Signaling, Metabolism, Signal Transduction, Stem Cells |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human | |||||||
| Mouse | |||||||
| Rat |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.